Bach Mark Allen has filed 4 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 65352 shares of Structure Therapeutics Inc. ($GPCR) on March 15, 2024.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 15, 2024 | Structure Therapeutics Inc. | $GPCR | Bach Mark Allen | CHIEF MEDICAL OFFICER | A | Stock Option (right to buy) | 65352 | $0.00 | 65,352.0000 | 110,198,000 | 9999.99% | 0.06% |
| March 15, 2024 | Structure Therapeutics Inc. | $GPCR | Bach Mark Allen | CHIEF MEDICAL OFFICER | A | Ordinary Shares | 26235 | $0.00 | 26,235.0000 | 110,198,000 | 9999.99% | 0.02% |
| March 15, 2024 | Structure Therapeutics Inc. | $GPCR | Bach Mark Allen | CHIEF MEDICAL OFFICER | A | Stock Option (right to buy) | 65352 | $0.00 | 65,352.0000 | 110,198,000 | 9999.99% | 0.06% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | Bach Mark Allen | Chief Medical Officer | P | American Depositary Shares | 1500 | $15.00 | 1,500.0000 | 9,584,000 | 9999.99% | 0.02% |